| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1091167146 |
| P356 | DOI | 10.1186/S13148-017-0382-Y |
| P932 | PMC publication ID | 5553900 |
| P698 | PubMed publication ID | 28811844 |
| P50 | author | Barbara A Foster | Q99207628 |
| Bryan Gillard | Q123019126 | ||
| Ellen Karasik | Q123019128 | ||
| P2093 | author name string | Jennifer Williams | |
| Sebastiano Battaglia | |||
| Michael T Moser | |||
| Dominic J Smiraglia | |||
| Trisha Winchester | |||
| P2860 | cites work | p53 is regulated by the lysine demethylase LSD1 | Q24292925 |
| The functional interactome landscape of the human histone deacetylase family | Q24294822 | ||
| LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer | Q24308737 | ||
| SUMOylation enhances DNA methyltransferase 1 activity | Q24311725 | ||
| LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription | Q24312958 | ||
| Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 | Q24336747 | ||
| Mapping a dynamic innate immunity protein interaction network regulating type I interferon production | Q24337463 | ||
| Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. | Q25256835 | ||
| Dysregulated transcriptional and post-translational control of DNA methyltransferases in cancer | Q26827297 | ||
| The role of histone demethylases in cancer therapy | Q26864687 | ||
| Alternative splicing of the histone demethylase LSD1/KDM1 contributes to the modulation of neurite morphogenesis in the mammalian nervous system | Q27659896 | ||
| A methylation and phosphorylation switch between an adjacent lysine and serine determines human DNMT1 stability | Q27666366 | ||
| Cancer statistics, 2014 | Q27861018 | ||
| Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy | Q28235397 | ||
| Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology | Q28269080 | ||
| Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence | Q28277232 | ||
| Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal | Q28288215 | ||
| The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation | Q28304726 | ||
| The vitamin D receptor (VDR) gene polymorphisms in Turkish brain cancer patients | Q28382894 | ||
| The mutational landscape of lethal castration-resistant prostate cancer | Q29614634 | ||
| Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease | Q29617086 | ||
| Vitamin D receptor regulates intestinal proteins involved in cell proliferation, migration and stress response | Q30317491 | ||
| Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor | Q30414643 | ||
| NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function. | Q30668571 | ||
| Vitamin D signaling regulates oral keratinocyte proliferation in vitro and in vivo | Q33637048 | ||
| A downstream intergenic cluster of regulatory enhancers contributes to the induction of CYP24A1 expression by 1alpha,25-dihydroxyvitamin D3. | Q33832689 | ||
| Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to Trichostatin A and 1alpha,25-dihydroxyvitamin D3. | Q40052462 | ||
| Androgen-receptor coregulators mediate the suppressive effect of androgen signals on vitamin D receptor activity | Q40439686 | ||
| Targeting 1alpha,25-dihydroxyvitamin D3 antiproliferative insensitivity in breast cancer cells by co-treatment with histone deacetylation inhibitors | Q40540512 | ||
| Current understanding of the molecular actions of vitamin D. | Q40838113 | ||
| Metastatic prostate cancer in a transgenic mouse | Q41167965 | ||
| The vitamin D hormone and its nuclear receptor: molecular actions and disease states. | Q41649611 | ||
| Characterization of Vitamin D insensitive prostate cancer cells | Q42269190 | ||
| Vitamin D receptor binds to the ε germline gene promoter and exhibits transrepressive activity | Q42868319 | ||
| Vitamin D receptor gene polymorphisms and breast cancer risk | Q45029601 | ||
| LSD1 demethylates histone and non-histone proteins. | Q46035931 | ||
| Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines. | Q64996606 | ||
| Phosphorylation of human DNMT1: implication of cyclin-dependent kinases | Q84084177 | ||
| Vitamin D receptor deficiency enhances Wnt/β-catenin signaling and tumor burden in colon cancer. | Q33999763 | ||
| Elevated NCOR1 disrupts PPARalpha/gamma signaling in prostate cancer and forms a targetable epigenetic lesion. | Q34094960 | ||
| Lysine-specific demethylase 1 regulates the embryonic transcriptome and CoREST stability | Q34178072 | ||
| Prostate cancer in a transgenic mouse | Q34444393 | ||
| The Molecular Taxonomy of Primary Prostate Cancer | Q34674332 | ||
| Androgen Receptor regulation of Vitamin D receptor in response of castration-resistant prostate cancer cells to 1α-Hydroxyvitamin D5 - a calcitriol analog | Q34943321 | ||
| The protective role of vitamin d signaling in non-melanoma skin cancer | Q35033717 | ||
| Active repression by unliganded retinoid receptors in development: less is sometimes more | Q35116527 | ||
| Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors | Q35133399 | ||
| Association of vitamin D receptor gene polymorphism with the urine calcium level in nephrolithiasis patients | Q35202376 | ||
| Regulation of mouse Cyp24a1 expression via promoter-proximal and downstream-distal enhancers highlights new concepts of 1,25-dihydroxyvitamin D(3) action | Q35858723 | ||
| Controlling nuclear receptors: the circular logic of cofactor cycles | Q36163600 | ||
| Epigenetic corruption of VDR signalling in malignancy | Q36555803 | ||
| The impact of chromatin organization of vitamin D target genes. | Q36555818 | ||
| Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns | Q36587617 | ||
| Identification of a 1,25-dihydroxyvitamin D3-response element in the 5'-flanking region of the rat calbindin D-9k gene | Q36789946 | ||
| Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules | Q36995427 | ||
| Cyclical chromatin looping and transcription factor association on the regulatory regions of the p21 (CDKN1A) gene in response to 1alpha,25-dihydroxyvitamin D3. | Q37134448 | ||
| Gene regulatory scenarios of primary 1,25-dihydroxyvitamin d3 target genes in a human myeloid leukemia cell line | Q37420569 | ||
| 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. | Q37958494 | ||
| Histone lysine demethylases as targets for anticancer therapy | Q38162717 | ||
| Regulation of protein stability of DNA methyltransferase 1 by post-translational modifications | Q38175783 | ||
| Vitamin D receptor overexpression in osteoblasts and osteocytes prevents bone loss during vitamin D-deficiency. | Q38179164 | ||
| Vitamin D and gene networks in human osteoblasts. | Q38208297 | ||
| Insulin-like growth factor binding protein-3 mediates 1 alpha,25-dihydroxyvitamin d(3) growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1. | Q38303196 | ||
| c-myc intron element-binding proteins are required for 1, 25-dihydroxyvitamin D3 regulation of c-myc during HL-60 cell differentiation and the involvement of HOXB4. | Q38326977 | ||
| Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells | Q38338010 | ||
| The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes | Q38345301 | ||
| Targeting Histone Demethylases: A New Avenue for the Fight against Cancer | Q38459037 | ||
| Lysine-specific demethylase 1 has dual functions as a major regulator of androgen receptor transcriptional activity. | Q38931537 | ||
| Vitamin D signaling regulates proliferation, differentiation, and myotube size in C2C12 skeletal muscle cells | Q39054183 | ||
| DC-SCRIPT: AR and VDR regulator lost upon transformation of prostate epithelial cells | Q39369871 | ||
| Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers | Q39723644 | ||
| Treatment of K562 cells with 1,25-dihydroxyvitamin D3 induces distinct alterations in the expression of apoptosis-related genes BCL2, BAX, BCLXL, and p21. | Q39846248 | ||
| P921 | main subject | vitamin D | Q175621 |
| P304 | page(s) | 82 | |
| P577 | publication date | 2017-08-11 | |
| P1433 | published in | Clinical Epigenetics | Q18620113 |
| P1476 | title | LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancer | |
| P478 | volume | 9 |
| Q54974720 | Epigenetic Regulation in Prostate Cancer Progression. |
| Q90080042 | Epigenetic Regulation of p21cip1/waf1 in Human Cancer |
| Q64089048 | The Function of the Vitamin D Receptor and a Possible Role of Enhancer RNA in Epigenomic Regulation of Target Genes: Implications for Bone Metabolism |
| Q55468580 | Without 1α-hydroxylation, the gene expression profile of 25(OH)D3 treatment overlaps deeply with that of 1,25(OH)2D3 in prostate cancer cells. |
Search more.